Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Smell training in CRS patients with smell loss

Official title: Cognitive and Immunologic Profiles of Patients With Olfactory Dysfunction After Smell Training

Run by The Cleveland Clinic · NCT07681973 · Data updated 2026-11-12

This study tests whether a 3-month smell training program can improve smell function and related immune and mental health measures in adults with chronic rhinosinusitis and smell loss.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment52 (estimated)
SponsorThe Cleveland Clinic
Academic / other
Locations1 site (Cleveland, Ohio)
StatusRecruiting
StartedDecember 9, 2025
Main results expectedDecember 31, 2026
Study endsMarch 31, 2027
Registry record updatedJuly 2, 2026
Trial IDNCT07681973 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with CRS with nasal polyps and documented smell loss, without autoimmune disease, ciliary disorders, cystic fibrosis, tumors, trauma-related smell loss, or unilateral polyps.

Probably not a fit

Individuals without CRS with nasal polyps or those whose smell loss is due to trauma or tumors may not benefit from this training.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with chronic rhinosinusitis with nasal polyps and smell loss will undergo a baseline assessment of smell function, mental health, disease severity, and immune markers, followed by a 3-month smell training program. A subset, including healthy controls, will provide comparison data and baseline measurements only. The study will analyze tissue and blood samples to find molecules linked to smell loss and explore potential links to cognition. Outcomes include changes in olfactory function, immune profile, and mental health after training. Control participants will not have follow-up testing beyond baseline.

Why it matters

Potential benefit: If successful, the training could offer a non-pharmacologic option to improve smell and related symptoms in CRS patients.

How similar studies have gone: Prior smell-training studies in CRS or smell loss have shown variable improvements, indicating potential but not conclusive benefit for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age less than 18 years-old
* Present to rhinology clinic with CRS with nasal polyps
* Sense of smell loss for any reason (other than trauma or tumor)

Exclusion Criteria:

* Patients \< 18 years of age
* Individuals with unilateral nasal polyps
* Autoimmune diseases
* Ciliary disorders
* Cystic fibrosis
* Smell loss due to tumors or trauma

Where it's running

  • The Cleveland Clinic
    Cleveland, Ohio, United States
    Recruiting

Study contacts

  • Principal investigator: Mohamad Chaaban, MD — The Cleveland Clinic
  • Study coordinator: John O'Neill
  • Email: ONEILLJ2@ccf.org
  • Phone: 4405062611

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.